Get the latest Zantac lawsuit updates and learn if you qualify to file your own product liability claim ... with cancer. This means that about 50,000 plaintiffs have had their cases rejected.

The case stems from claims emerging in 2019 that Zantac (ranitidine) or generic versions caused cancer and other illnesses ... but this was rejected and the decision is final and cannot be appealed.

The recent settlement was made to resolve most of the claims in U.S ... a Florida district judge rejected the science backing the claims that Zantac can cause cancer. The ruling freed the ...

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion ... its heartburn drug Zantac caused cancer. The company said it ...

The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.

They accused the drugmakers of engaging in a decades-long scheme to conceal the dangers and risks associated with Zantac use ... they developed cancer. The medical monitoring claims, brought ...